GlobeNewswire·Sep 21, 2026, 8:30 AM ET

PetMeds Enhances Board of Directors with Appointment of Tamar Elkeles as New Independent Director

PetMed Express, Inc. (NASDAQ: PETS) appointed Tamar Elkeles, PhD as a new independent director & Chair of the Compensation & Human Capital Committee effective September 17, 2026.
Dr. Elkeles brings over three decades of executive experience in technology, enterprise software, & human capital industries, including a tenure as Chief Learning & Talent Officer at Qualcomm from 1992 to 2015.
During her time at Qualcomm, she supported revenue growth from $100 million to over $25 billion & expanded the global workforce from 700 to 35,000 employees.
Dr. Elkeles currently serves as a Senior Advisor at East Wind Advisors, an Advisor at 444 Capital, a Venture Partner at Emerge Capital, & sits on the boards of Brightline Interactive & Open Sesame.
The appointment follows the recent leadership transition where Jeff Willard was appointed Chief Executive Officer & President, succeeding Interim CEO Leslie C.G. Campbell.
Incoming Board Chair Justin Mennen stated that Dr. Elkeles' expertise in building high-performing cultures will be an asset as PetMeds scales & executes on long-term growth priorities.
PetMeds, founded in 1996, operates as a licensed national online pharmacy across all 50 states & offers pet health solutions through its PetCareRx subsidiary.